China Healthwise Holdings Limited (HKG:0348)

Market Cap	67.49M -43.1%
Revenue (ttm)	84.97M -18.1%
Net Income	-33.12M
EPS	-0.04
Shares Out	924.57M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	90,000
Open	0.0660
Previous Close	0.0740
Day's Range	0.0660 - 0.0740
52-Week Range	0.0510 - 0.2200
Beta	-0.47
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 27, 2026

About China Healthwise Holdings

China Healthwise Holdings Limited, an investment holding company, engages in the sale of Chinese health products in Hong Kong. It operates through three segments: Chinese Health Products, Money Lending Business, and Investment in Financial Instruments. The company sells Chinese and other pharmaceutical products, health products, ginseng, and dried seafood products to wholesalers and retailers; and trades and retails Sum Yung and dried seafood under the Nam Pei Hong brand name. It is also involved in money lending business; and invests in financ...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 1997
• Employees: 70
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 0348

Financial Performance

In 2025, China Healthwise Holdings's revenue was 99.56 million, a decrease of -12.34% compared to the previous year's 113.58 million. Losses were -2.61 million, -93.53% less than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 2, 2026

Data Sources Report a data error